About us
Our research focuses on clinical and translational research in prognostics and therapeutics for keratinocyte carcinomas.
Our research:
Identifying high-risk cutaneous squamous cell carcinomas and basal cell carcinomas.
Understanding the optimal approach to management of aggressive cutaneous squamous cell carcinomas and basal cell carcinomas.
Optimizing workup and surveillance protocols for cutaneous squamous cell carcinomas and basal cell carcinomas.
Utilizing novel techniques in the management of cutaneous squamous cell carcinoma and basal cell carcinoma.
Current Research
Cutaneous squamous cell carcinoma prognostication
· Developing a prognostic app utilizing data from more than 10 centers across the world to help predict risk for individual patients with cutaneous squamous cell carcinoma.
· Understanding how gene expression profile can influence management in patients with cutaneous squamous cell carcinoma.
· Utilizing artificial intelligence to prognosticate for cutaneous squamous cell carcinomas.
Cutaneous squamous cell carcinoma surveillance
· Validating dermatologist-performed ultrasound to monitor for lymph node metastasis in patients with high-risk cutaneous squamous cell carcinoma
· Developing algorithms for surveillance following treatment of an advanced cutaneous squamous cell carcinoma
Translational Research
· Understanding the tumor microenvironment in patients with chronic lymphocytic leukemia and cutaneous squamous cell carcinoma
